Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  EntreMed Inc    

SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops pharmaceutical drugs for treating cancer and inflammatory diseases

CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs with commercial focus on the China market.

The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau.

The drugs are Captisol-Enabled, ZEVALIN and MARQIBO.

CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.
Managers
NameAgeSinceTitle
Ken Keyong Ren MD, PhD582012Chief Executive Officer & Director
Wei-Wu He PhD, MBA522012Executive Chairman
Cynthia Wong Hu472006COO, Secretary, Vice President & General Counsel
Sara B. Capitelli, CPA502011Chief Accounting Officer & Vice President-Finance
Zuie Chin Huang, MBA522013Independent Director
Yue Alexander Wu PhD, MBA532013Independent Director
Franklin Cary Salisbury, Jr.612014Independent Director
Rajesh C. Shrotriya, MD732014Independent Director
Quan Zhou, PhD592016Director
James E. Goldschmidt, PhD-2016Vice President-Business Development
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 60,276,119 33,568,939 55.7% 79,545 0.1% 55.7%
Shareholders
NameEquities%
Spectrum Pharmaceuticals, Inc. 10,028,579 16.7%
He Xie Ai Qi Investment Management Beijing Co. Ltd. 8,498,765 14.1%
IDG Capital Partners Co., Ltd. 6,842,783 11.4%
Zhejiang Kanglaite Group Co. Ltd. 2,469,135 4.10%
Celgene Corp. 2,464,987 4.09%
Emerging Technology Partners LLC 2,312,677 3.84%
Wellington Shields Capital Management LLC 528,447 0.88%
Wellington Shields & Co. LLC 505,474 0.84%
Kleiner Perkins Caufield & Byers LLC 416,666 0.69%
Tak W. Mak, PhD 365,376 0.61%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
ENTREMED INC87
INCYTE CORPORATION21.62%23 098
QUINTILES IMS HOLDINGS..2.72%18 414
CELLTRION, INC.--.--%11 010
LONZA GROUP AG2.67%10 420
SEATTLE GENETICS, INC.19.52%8 928
ALKERMES PLC-5.42%8 019
QIAGEN NV-2.67%6 537
UNITED THERAPEUTICS CO..2.80%6 254
IONIS PHARMACEUTICALS ..-7.28%5 375
ACADIA PHARMACEUTICALS..37.17%4 791
ICON PLC13.50%4 785
CHARLES RIVER LABORATO..15.25%4 160
ALNYLAM PHARMACEUTICAL..23.53%3 978
BIO-TECHNE CORP3.41%3 968
PRA HEALTH SCIENCES IN..10.78%3 750
PAREXEL INTERNATIONAL ..0.24%3 357
GALAPAGOS7.98%3 218
BB BIOTECH AG4.45%3 169
INC RESEARCH HOLDINGS ..5.89%2 986
INTREXON CORP-9.34%2 612
Sector Biotechnology & Medical Research - NEC
EntreMed Inc : Connections
IDG Technology Venture Investment, Inc.
Human Longevity, Inc.
National Foundation for Cancer Research
Superdata Software Holdings Ltd.
Emerging Technology Partners LLC
Amnis Corp.
Allos Therapeutics, Inc.
Wuhan Kindstar Diagnostics Co., Ltd.
MithraGen, Inc.
Intradigm Corp.
IDG Technology Venture Investment IV LLC
Beijing Genetron Biotechnology Co. Ltd.
OriGene Technologies, Inc.
IDG Capital Partners Co., Ltd.
Cytomyx Holdings Plc
Circle Internet Financial, Inc.
The UNLV Foundation
American-Sino OB/GYN Hospital
ImmunoVentis, Inc.
CVie Therapeutics Co. Ltd.
Zenesis Ltd.
OMNI Pharmaceuticals (USA), Inc.
WUPIMA, Inc.
Smooth Prosper Ltd.
Creditease Holdings Cayman Ltd.
GenScript Corp.
MZ Investment Holdings Ltd.
KPCB China Fund II LP
IDG Technology Venture Investment III LLC
Crown Bioscience, Inc.
IDG Technology Venture Investments LP
Company contact information
CASI Pharmaceuticals, Inc.
9620 Medical Center Drive
Suite 300
Rockville, MD 20850

Phone : +1.240.864.2600
Fax : +1.240.315.2437
Web : www.casipharmaceuticals.com
© 2017 People , Fundamentals and Ownership